Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
US |
|
I
|
Ideanomics Inc
LSE:0A4F
|
US |
|
Happinet Corp
TSE:7552
|
JP |
|
S
|
Sigma Lithium Corp
NASDAQ:SGML
|
CA |
|
Werner Enterprises Inc
NASDAQ:WERN
|
US |
|
Romande Energie Holding SA
SIX:HREN
|
CH |
|
Himatsingka Seide Ltd
NSE:HIMATSEIDE
|
IN |
|
Jefferies Financial Group Inc
NYSE:JEF
|
US |
|
BB Seguridade Participacoes SA
BOVESPA:BBSE3
|
BR |
|
F
|
Fast Retailing Co Ltd
OTC:FRCOF
|
JP |
|
Rewalk Robotics Ltd
NASDAQ:LFWD
|
IL |
|
Y
|
Yellow Cake PLC
XBER:0LZ
|
JE |
|
S
|
Silverco Mining Ltd
OTC:SICOF
|
CA |
|
S
|
Schnitzer Steel Industries Inc
F:SS1A
|
US |
|
FS Bancorp Inc
NASDAQ:FSBW
|
US |
|
S
|
Sanofi SA
XMUN:SNW
|
FR |
|
News Corp
NASDAQ:NWSA
|
US |
Bankruptcy Probability
Y-mAbs Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Y-mAbs Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
391.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Y-mAbs Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Y-mAbs Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
